Aurobindo Pharma Limited (BOM:524804)
India flag India · Delayed Price · Currency is INR
1,148.50
-9.05 (-0.78%)
At close: Feb 13, 2026

Aurobindo Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Market Capitalization
665,366674,020637,941303,575391,729516,388
Market Cap Growth
-2.61%5.66%110.14%-22.50%-24.14%113.31%
Enterprise Value
654,315689,676632,994283,996394,408532,915
Last Close Price
1148.501155.361085.37513.78653.74855.88
PE Ratio
19.0819.3420.1115.7514.799.68
PS Ratio
2.012.132.201.221.672.08
PB Ratio
1.902.072.141.131.592.36
P/TBV Ratio
2.182.362.461.311.852.73
P/FCF Ratio
-34.45--13.2227.31
P/OCF Ratio
-17.1726.2012.727.8115.51
EV/Sales Ratio
1.972.172.181.141.682.15
EV/EBITDA Ratio
9.7210.6410.987.819.159.88
EV/EBIT Ratio
12.7013.7114.4111.3111.9311.97
EV/FCF Ratio
-35.25--13.3128.18
Debt / Equity Ratio
0.220.250.220.200.120.24
Debt / EBITDA Ratio
1.151.261.141.430.650.97
Debt / FCF Ratio
-4.22--0.962.82
Net Debt / Equity Ratio
-0.030.000.01-0.04-0.07-0.01
Net Debt / EBITDA Ratio
-0.160.010.06-0.26-0.40-0.05
Net Debt / FCF Ratio
-0.03-0.9355.51-0.58-0.15
Asset Turnover
-0.670.680.670.690.79
Inventory Turnover
-1.331.421.451.261.22
Quick Ratio
-0.990.960.981.100.90
Current Ratio
-1.851.981.882.221.86
Return on Equity (ROE)
-11.15%11.18%7.50%11.39%27.53%
Return on Assets (ROA)
-6.63%6.46%4.25%6.10%8.87%
Return on Invested Capital (ROIC)
10.32%11.01%11.33%7.60%11.66%15.57%
Return on Capital Employed (ROCE)
-14.30%13.40%8.80%12.80%19.20%
Earnings Yield
5.24%5.17%4.97%6.35%6.76%10.33%
FCF Yield
-2.90%-0.54%-0.06%7.56%3.66%
Dividend Yield
0.35%-0.41%0.58%1.38%0.47%
Payout Ratio
-0.03%8.31%22.80%9.96%4.39%
Buyback Yield / Dilution
0.50%0.52%----
Total Shareholder Return
0.85%0.52%0.41%0.58%1.38%0.47%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.